Reference · Coverage · Florida
Florida: four TRT programs publish coverage, thirteen establish nothing
Florida is the permissive case in this edition, and that is the finding. Across 17 prescription TRT records, 4 publish a state list that includes Florida and 0 publish a list that excludes it. The remaining 13 publish nothing that decides the question — so the state's real answer is a distribution, not a yes.
In one sentence
Nothing published in this edition restricts Florida and nothing publishes a Florida price, but only 4 of 17 programs publish a coverage list that names the state, and of those 4 exactly 1 publishes a monthly cost you can total — Fountain TRT.
- 4 of 17
- Publish a state list that includes Florida
- 13 of 17
- Publish no readable state list at all
- 0
- Publish a list that leaves Florida out
- 1 of 4
- Of those, publish a complete monthly cost
a published list is the only evidence accepted here
recorded as unknown, never as unavailable and never as nationwide
no record in this edition excludes the state
the other three cannot be totalled from what they publish
The short answer
Florida is the permissive case in this edition, and that is the whole finding. No record publishes a Florida exclusion, no record publishes a Florida price, and no record in this edition publishes an in-person visit requirement at all — which is a statement about their pages, not about the law. But permissive is not the same as established: 4 programs publish Florida on their own coverage list and 13 publish nothing that establishes eligibility either way. Of the four that do, exactly 1 publishes a monthly figure you can actually total — Fountain TRT at $199.00/mo.
What a Florida price would look like
Nothing on this page is a Florida rate. The 3 published figures across these four programs are the same national charges every other state sees, printed beside a state list that happens to include Florida. A program that charges more in Florida would be the first evidence of it in this edition.
0 state-specific amounts in 17 records
National advertising is not evidence of Florida eligibility. A program that markets in every market and never publishes a state list is counted here as unknown — 13 records are in that position — because a blank list is a fact about the research, not a licence to assume coverage. Nothing in the edition publishes a Florida exclusion either, so there is no state on the other side of the ledger: the honest answer is a distribution of evidence, not a verdict on the state.
The 4 programs that publish Florida, and what each one actually charges
4 of 17 prescription TRT recordsEvery row below was read from the program’s own page, and the state list printed there includes Florida. None of these amounts is a Florida amount: they are the same published charges a buyer sees anywhere the program operates. The last column is the one that decides whether a published rate becomes a bill.
- Hims & Hers49 states
Injectable vial; oral capsules also listed
- Published charge
- Compounded injectable from $79/mo, medication only
- Known monthly
- $79.00/mo
- Leaves out
- membership unpriced
Checked Oct 26, 2026Source - Marek HealthAll 50 states
Formulation not established in the sources read
- Published charge
- No monthly charge published
- Known monthly
- Not established
- Leaves out
- No charge published
Checked Oct 26, 2026Source - Fountain TRT20 states
Topical testosterone cream
- Published charge
- From $199/mo, published as a flat all-inclusive monthly fee
- Known monthly
- $199.00/mo
- Leaves out
- Nothing
Checked Oct 26, 2026Source - Peter MD (Peter Uncaged)48 states
Injectable testosterone cypionate
- Published charge
- $139/mo on the one-month plan
- Known monthly
- $139.00/mo
- Leaves out
- labs unpriced
Checked Oct 26, 2026Source
The spread is smaller than it looks
The published monthly figures across these four run from $79.00/mo to $199.00/mo. That range mixes a medication rate with a membership excluded, a rate with a required lab panel unpriced, and a rate that is genuinely all-in — so the cheapest number on the table is the one least likely to become a final bill.
One list is not like the others
One of these publishes all fifty states, two publish in the high forties, and one publishes twenty. All four include Florida, which is why the state can be answered at all — but a twenty-state program and a fifty-state program are not the same product, and the column above keeps the difference visible instead of flattening it into “available in Florida”.
13 programs say nothing that decides Florida — and that is the largest group
The missing evidence, recordedThis is the honest centre of the page. Most of the online TRT market does not publish a readable list of the states it serves, so for most programs there is no Florida fact to report — which is a different thing from a Florida restriction, and a very different thing from availability. Each row below keeps the provider’s own wording so the gap can be read rather than taken on trust.
Its own pages disagree
1These records do address coverage, and their own pages contradict each other. No single list can be built from contradictory claims, so no Florida answer exists to publish.
- Male ExcelConflicts
Male Excel contradicts itself: its locations page claims 49 states and DC, its homepage lists exclusions beginning with AL, AK, AR, CT, HI and ID, a third-party comparison says 35 states, and a 2026 release says all 50. No single list is recorded against four conflicting claims.
States excluded, no served list
1This record names states it does not ship to and does not name Florida among them — but it also admits one exclusion it never names. A state missing from an exclusion list is not a state on a served list.
- Blokes (Joi + Blokes)Exclusions
Blokes states it ships testosterone to all but 15 states, and names 14 exclusions (AL, AR, CT, DE, GA, HI, LA, MN, MO, NC, ND, OK, PA, RI). With one exclusion unnamed, no served list can be built, so only the exclusions are published.
No readable served list
11These may mention coverage, restrict lab kits by state, or refer to a list they never publish — but none publishes a readable served list, so Florida cannot be placed either way.
- Hone HealthNo list
Hone publishes availability by state, but its own pages put coverage at 35 states in one place and 36 in another, and no complete public list could be read. Coverage is therefore not recorded as nationwide.
- LifeMDNo list
The XYOSTED program launched in 37 states in July 2026, at-home lab kits are unavailable to residents of NJ, NY and RI, and LifeMD states availability varies by state. No complete list is published.
- RexMDNo list
RexMD publishes no state list, so coverage is recorded as unestablished.
- Maximus (Maximus Tribe)No list
Maximus is marketed as nationwide, but its oral protocols are not offered in every state and it publishes no list. The 2022 release that excluded AL, AK, IN and DC is dated and is not used to build a list.
- Defy MedicalNo list
Defy publishes no state list, so coverage is recorded as unestablished.
- Taurus MedsNo list
Taurus publishes no state list, so coverage is recorded as unestablished.
- ReformHRTNo list
No policy page could be read for ReformHRT, so cancellation, refunds and coverage all stay unestablished rather than being inferred.
- RegenX HealthNo list
REGENX states that telehealth regulation varies by state and refers to a full list, but no readable state list was published and third-party reviewers report the same gap.
- Titan TRTNo list
Titan publishes no state list on titan-trt.com, so coverage is unestablished.
- KeepsNo list
The jointitan.com page operated by Keeps publishes no state list, and no policy page was reachable from it, so coverage is recorded as unestablished.
- AlynMDNo list
alynmd.com resolves to a GoDaddy parked /lander page rather than a provider site, checked on 2026-10-26, so no coverage statement and no policy page could be read. Cancellation, refunds and the state list all stay unestablished, and the record carries no outbound link.
Why these are not filed under “unavailable”
A provider that treats in 40-odd states and simply never publishes which ones is very likely to treat in Florida. Filing that as unavailable would be wrong in the more damaging direction: it would tell a buyer a program is closed to them on the strength of an absence. Filing it as available would be wrong too. It stays unknown, and the fix is one question to the program — do you prescribe to a Florida address, and which clinician is licensed or registered to do it?
The one fact a buyer can check directly
Florida requires an out-of-state clinician to register with the state before treating a Florida patient, and the Department of Health must publish every registrant with their licence, specialty, five-year disciplinary history and malpractice cover. No record in this edition states which clinician treats Florida patients or under what licence, so that list is the only place the answer exists.
Florida DOH telehealthThe rules that decide Florida eligibility — read from the statute, not from advertising
Read Oct 30, 2026A provider page tells you what a program charges. It does not tell you whether the program may treat you. Those are two separate questions, and Florida answers the second one in statute. Six sources, each dated, each linked.
- 01
The telehealth practice standard
Fla. Stat. § 456.47(2)(a)–(b)A telehealth provider may use telehealth to perform a patient evaluation, and if that evaluation is sufficient to diagnose and treat, the provider is not required to research the patient’s medical history or conduct a physical examination first. The duty to meet the same professional standard as in-person care still applies.
- 02
The controlled-substance bar
Fla. Stat. § 456.47(2)(c)A telehealth provider may not use telehealth to prescribe a Schedule II controlled substance, except for a psychiatric disorder, inpatient hospital treatment, hospice care or a nursing-home resident. The bar is written against Schedule II only.
- 03
Where testosterone sits
Fla. Stat. § 893.03(3)Florida schedules anabolic steroids in Schedule III. Testosterone is an anabolic steroid, so on the face of the statute it is not one of the Schedule II substances § 456.47(2)(c) bars a telehealth provider from prescribing.
- 04
Who may treat a Florida patient
Fla. Stat. § 456.47(4)A practitioner not licensed in Florida must register with the applicable board before treating a patient located in Florida, must carry liability cover that reaches Florida patients, and may not open an office in the state or provide in-person services there.
- 05
The public registrant list
Fla. Stat. § 456.47(4)(h); Fla. Dep’t of HealthThe department must publish a list of every registered out-of-state telehealth provider, including licence, specialty, five-year disciplinary history and malpractice cover. This is the one Florida-specific fact about a prescriber that a buyer can check directly.
- 06
The federal layer, and its expiry
DEA / HHS temporary rule, fourth extensionFederal telemedicine flexibilities for prescribing controlled medications were extended through December 31, 2026. Florida’s own statute does not require an in-person visit for testosterone, but the federal basis for prescribing it without one is temporary and was not replaced by a permanent rule on the check date.
The date that matters most
Florida’s statute is not the binding constraint here — the federal rule is, and it is temporary. Prescribing a controlled substance by telemedicine without a prior in-person examination rests on a DEA/HHS flexibility that runs to December 31, 2026. On the check date it had not been replaced by a permanent rule. A Florida buyer signing up near that date is buying a program whose federal footing could change, and no provider page in this edition addresses what happens to existing patients if it does.
What the statute does not say
- It does not require an in-person exam before a testosterone prescription, so no record’s silence about one is a restriction.
- It does not set a Florida price, a Florida fee, or a Florida plan. Nothing in the statute touches billing.
- It does not certify any program in this edition, and it says nothing about whether a given clinician is registered.
This is what the sources say, not legal advice, and it does not establish that any program in this edition complies. A program listed here may use a Florida-licensed clinician, a registered out-of-state clinician, or both, and no record in this edition states which.
The only place a state price could appear
A state comparison would be worth far more with a Florida rate in it. There is exactly one published statement in the record set that even acknowledges state-level pricing, and it carries no number.
The record notes that the treatment page prices by dosage and plan length and states that pricing may vary slightly by state.
No amount is attached to the variation, and the record publishes no state list, so this is not a Florida price and not a Florida restriction.
Provider pageWhat this page refuses to do
- It does not say a program is available in Florida unless that program’s own page lists the state.
- It does not convert a blank state list into a yes or a no. Blank stays unknown, in both directions.
- It does not publish a Florida price, because no record in this edition carries one.
- It does not claim any program complies with Florida telehealth law. It records what the law requires.
- It does not rank, score or recommend. The four programs appear in the order the record set returns them.
- It does not do cities. A city page built from a state list would claim a local presence no program publishes.